Literature DB >> 1373204

Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes.

L C Dai1, K West, R Littaua, K Takahashi, F A Ennis.   

Abstract

A human leukocyte antigen A24-restricted CD8+ cytotoxic T-cell clone specific for gp41 of human immunodeficiency virus type 1 was isolated from an infected individual. The epitope was localized to amino acids 584 to 591 (YLKDQQLL, NL43 env sequence) of gp41 by using a panel of recombinant vaccinia viruses that contain truncated env genes and synthetic peptides. The clone killed autologous B-lymphoblastoid cell lines pulsed with a synthetic peptide reflecting the sequence of the IIIB and MN strains. This clone, however, failed to kill target cells pulsed with the peptides that have a mutation from Lys to Arg or Gln at amino acid 585 which is present in some prototype human immunodeficiency virus type 1 strains, e.g., ADA, JFL, SC, ALA1, BAL1, SF2, VRF, SF33, and WMJ2. This finding that a mutation at amino acid 585 on gp41 results in nonrecognition by human leukocyte antigen A24-restricted CD8+ cytotoxic T lymphocytes suggests that antigenic variation at T-cell epitopes contributes to the failure of immune control of human immunodeficiency virus type 1 infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373204      PMCID: PMC241078     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.

Authors:  P L Earl; S Koenig; B Moss
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine.

Authors:  R J Orentas; J E Hildreth; E Obah; M Polydefkis; G E Smith; M L Clements; R F Siliciano
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

3.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.

Authors:  D F Nixon; A R Townsend; J G Elvin; C R Rizza; J Gallwey; A J McMichael
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

4.  Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein.

Authors:  S Koenig; T R Fuerst; L V Wood; R M Woods; J A Suzich; G M Jones; V F de la Cruz; R T Davey; S Venkatesan; B Moss
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

5.  Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein.

Authors:  K Takahashi; L C Dai; T R Fuerst; W E Biddison; P L Earl; B Moss; F A Ennis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

6.  An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag.

Authors:  R A Littaua; M B Oldstone; A Takeda; C Debouck; J T Wong; C U Tuazon; B Moss; F Kievits; F A Ennis
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

7.  Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells.

Authors:  S A Hammond; E Obah; P Stanhope; C R Monell; M Strand; F M Robbins; W B Bias; R W Karr; S Koenig; R F Siliciano
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

8.  A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6.

Authors:  R A Littaua; M B Oldstone; A Takeda; F A Ennis
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

9.  Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals.

Authors:  M Clerici; D R Lucey; R A Zajac; R N Boswell; H M Gebel; H Takahashi; J A Berzofsky; G M Shearer
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

10.  In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific.

Authors:  A E Lukacher; V L Braciale; T J Braciale
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

View more
  23 in total

1.  Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells.

Authors:  O O Yang; A C Tran; S A Kalams; R P Johnson; M R Roberts; B D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing.

Authors:  R Maier; K Falk; O Rötzschke; B Maier; V Gnau; S Stevanović; G Jung; H G Rammensee; A Meyerhans
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

3.  Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A*2402 molecules.

Authors:  M Ibe; Y I Moore; K Miwa; Y Kaneko; S Yokota; M Takiguchi
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 4.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes.

Authors:  S Chada; C E DeJesus; K Townsend; W T Lee; L Laube; D J Jolly; S M Chang; J F Warner
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-cell clone.

Authors:  I Kurane; L C Dai; P G Livingston; E Reed; F A Ennis
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Authors:  Rachid Boucherma; Hédia Kridane-Miledi; Romain Bouziat; Michael Rasmussen; Tanja Gatard; Francina Langa-Vives; Brigitte Lemercier; Annick Lim; Marion Bérard; Lbachir Benmohamed; Søren Buus; Ronald Rooke; François A Lemonnier
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

9.  Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones.

Authors:  S J Gagnon; W Zeng; I Kurane; F A Ennis
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus.

Authors:  M J Gilbert; S R Riddell; C R Li; P D Greenberg
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.